Fisher And Paykel Healthcare Corpo revenue and financials
$37.69Change from previous close: +0.96%Absolute change: +$0.36
In the fiscal year ended March 2026, Fisher And Paykel Healthcare Corpo reported revenue of $2.31B (+80.30% year over year). Net income was $468.5M, a net margin of 20.3%.
Fiscal year ending in March. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +80.30%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +24.20%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 20.3%
- FY to Mar 2025: 29.5%
Financial data
Amounts in millions of NZD; per-share values in NZD; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 |
|---|---|---|---|---|---|
| Total assets | 2,854 | 2,551 | 2,282 | 2,205 | — |
| Current assets | 1,152 | 935 | 705 | 774 | — |
| Cash and equivalents | 461 | 265 | 82.0 | 121 | — |
| Short-term investments | — | — | — | — | 200 |
| Receivables | 329 | 305 | 257 | 219 | — |
| Inventory | 327 | 343 | 320 | 366 | — |
| Net property, plant and equipment | 1,407 | 1,339 | 1,340 | 1,148 | — |
| Other intangible assets | 72.7 | 82.1 | 88.4 | 85.6 | — |
| Current liabilities | 498 | 500 | 385 | 290 | — |
| Accounts payable | 56.7 | 52.9 | 32.4 | 43.0 | — |
| Long-term debt | 52.5 | — | 35.7 | 79.1 | 63.0 |
| Total debt | 146 | 153 | 189 | 146 | — |
| Total liabilities | 738 | 660 | 523 | 451 | — |
| Total equity (incl. minority) | 2,115 | 1,890 | 1,759 | 1,753 | — |
| Retained earnings | 1,443 | 1,227 | 1,095 | 1,201 | — |